Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
- 1 February 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 9 (1) , 65-83
Abstract
(2009). Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 9, No. 1, pp. 65-83. doi: 10.1586/14737167.9.1.65Keywords
This publication has 45 references indexed in Scilit:
- Insight into recent reforms and initiatives in Austria: implications for key stakeholdersExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Doctors’ education: the invisible influence of drug company sponsorshipBMJ, 2008
- Balancing Big Pharma’s booksBMJ, 2008
- Recent National and Regional Drug Reforms in SwedenPharmacoEconomics, 2008
- Having Your Cake and Eating ItPharmacoEconomics, 2008
- Impact of quality circles for improvement of asthma care: results of a randomized controlled trialJournal of Evaluation in Clinical Practice, 2007
- How can we regulate medicines better?BMJ, 2007
- How much will Herceptin really cost?BMJ, 2006
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006
- Why Did Drug Spending Increase During the 1990s?PharmacoEconomics, 2004